O
Owkin
Biotech & Life Sciences · Paris, France · Founded 2016 Unicorn
Investors
28 investors on Owkin's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Ownership
Who owns Owkin
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (Mar/2026). Percentages are indicative.
Some investors are hidden on this public profile. See the full cap table on Dealroom →
Owkin mafia
Startups founded by Owkin alumni
Former Owkin employees who went on to start their own companies. Sorted by Dealroom signal score.
Thomas ClozelFrance
Simon IstolainenFrance
Pierre ManceronFrance
Mathieu GaltierFrance
Pierre CourtiolFrance
Julien PinedeUnited States
Adrian GonzálezFrance
Vincent LepageFrance
Jerome PesentiUnited StatesGlobal footprint
Where Owkin has talent and traffic
team presence
across markets
Talent graph
The shape of Owkin's talent
Dealroom maps Owkin's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$2M patent portfolio · 9 active families
Where Owkin concentrates vs peers
Each axis is a top-10 topic across Owkin and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Owkin's 3 investments and acquisitions.
Every disclosed deal where Owkin appeared as a backer or acquirer, 2023–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Owkin's capital deployment.
Where the deals concentrate by sector, stage, and decade.
01 · Deployment strategy vs peers
Where Owkin deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
02 · Portfolio market map
Owkin's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Owkin
An AI-synthesized read of the highest-engagement posts about Owkin on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Owkin on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.